Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly A Holmes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2015
Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast CancerKelly A Holmes, Gordon D Brown, Jason S Carroll
Frontiers in Oncology|February 20, 2013
FOXA1 mutations in hormone-dependent cancersJessica L L Robinson, Kelly A Holmes, Jason S Carroll
Cancer Research|September 17, 2008
Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activityKelly A Holmes, Jun S Song, Xiaole S Liu, et al.
Nature Genetics|December 15, 2010
FOXA1 is a key determinant of estrogen receptor function and endocrine responseAntoni Hurtado, Kelly A Holmes, Caryn S Ross-Innes, et al.
Plos One|April 11, 2019
Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alphaSilvia-E Glont, Evangelia K Papachristou, Ashley Sawle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cellsKelly A Holmes, Antoni Hurtado, Gordon D Brown, et al.
Genes & Development|January 19, 2010
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancerCaryn S Ross-Innes, Rory Stark, Kelly A Holmes, et al.
Nature|November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenAntoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Nature|January 6, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerCaryn S Ross-Innes, Rory Stark, Andrew E Teschendorff, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2015
Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast CancerKelly A Holmes, Gordon D Brown, Jason S Carroll
Frontiers in Oncology|February 20, 2013
FOXA1 mutations in hormone-dependent cancersJessica L L Robinson, Kelly A Holmes, Jason S Carroll
Cancer Research|September 17, 2008
Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activityKelly A Holmes, Jun S Song, Xiaole S Liu, et al.
Nature Genetics|December 15, 2010
FOXA1 is a key determinant of estrogen receptor function and endocrine responseAntoni Hurtado, Kelly A Holmes, Caryn S Ross-Innes, et al.
Plos One|April 11, 2019
Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alphaSilvia-E Glont, Evangelia K Papachristou, Ashley Sawle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cellsKelly A Holmes, Antoni Hurtado, Gordon D Brown, et al.
Genes & Development|January 19, 2010
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancerCaryn S Ross-Innes, Rory Stark, Kelly A Holmes, et al.
Nature|November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenAntoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Nature|January 6, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerCaryn S Ross-Innes, Rory Stark, Andrew E Teschendorff, et al.
Pageof 2